13 results on '"Joshi, Shalina"'
Search Results
2. Long-Term Follow-up of Outcomes with Ptcy Gvhd Prophylaxis in PBSC Transplant: Decreased Chronic Gvhd and Improved Non-Relapse Mortality.
3. A Comparative Analysis of Engraftment Outcomes for Recipients of Allogeneic Hematopoietic Stem Cell Transplants (allo HSCT) and Post-Transplant Cyclophosphamide (PTCy) Based on Ideal Body Weight (IBW) or Actual Body Weight (ABW) Dosing of CD34-Positive Stem Cells
4. Day 30 and Day 100 CD3 Chimerism Levels Are Not Predictive of Progression Free Survival, Overall Survival and Gvhd Outcomes in Allogenic Stem Cell Transplants Using Post-Transplant Cyclophosphamide
5. Effects of Pubertal Exposure to Butyl Benzyl Phthalate, Perfluorooctanoic Acid, and Zeranol on Mammary Gland Development and Tumorigenesis in Rats
6. Combined Inhibition of AKT and KIT Restores Expression of Programmed Cell Death 4 (PDCD4) in Gastrointestinal Stromal Tumor
7. Retrospective Analysis of Efficacy and Toxicity of Melphalan 200mg/m2 and 140mg/m2 for Autologous Stem Cell Transplant in Multiple Myeloma
8. Effects of Post-Transplant Cyclophosphamide on Early Donor Chimerism Outcomes after Allogeneic Stem Cell Transplant with Busulfan Based Myeloablative Conditioning
9. 418 - Day 30 and Day 100 CD3 Chimerism Levels Are Not Predictive of Progression Free Survival, Overall Survival and Gvhd Outcomes in Allogenic Stem Cell Transplants Using Post-Transplant Cyclophosphamide
10. The Impact of Peripheral Stem Cell As a Stem Cell Source on Gvhd for Patients Receiving Post-Transplant High Dose Cyclophosphamide As Gvhd Prophylaxis after an Allogeneic Transplant
11. 500 - Retrospective Analysis of Efficacy and Toxicity of Melphalan 200mg/m2 and 140mg/m2 for Autologous Stem Cell Transplant in Multiple Myeloma
12. 251 - Effects of Post-Transplant Cyclophosphamide on Early Donor Chimerism Outcomes after Allogeneic Stem Cell Transplant with Busulfan Based Myeloablative Conditioning
13. Abstract 4808: Combinations of imatinib mesylate with AKT inhibitor (miransertib, ARQ 751) or FGFR inhibitor (derazantinib) show synergy in GIST cell lines and preclinical models
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.